Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Multiple Myeloma × Renal Replacement Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1 Genitourinary 1

Conditions

Multiple Myeloma 1 Acute Kidney Injury 1

Interventions

Dexamethasone 3 Cyclophosphamide 3 pegylated granulocyte colony-stimulating factor 2 pegfilgrastim 2 carfilzomib 2 Etoposide 2 Cytarabine 2 Bortezomib 2 pomalidomide 1 fludarabine 1 daratumumab 1 Zoledronic Acid 1 Vaccination 1 Thiotepa 1 Renal Replacement Therapy 1 Prednisone 1 Pneumococcal Vaccines 1 Melphalan 1 Lenalidomide 1 Granulocyte Colony-Stimulating Factor 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02358980 2025-06-25

KEEPER

Azienda USL Reggio Emilia - IRCCS

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡